
This session explores how pharmaceutical companies are using advanced modeling, simulation, and AI-enabled digital twins to accelerate innovation, improve manufacturing efficiency, and streamline regulatory compliance. In this webinar, ARC's Director of Consulting Rick Rys will outline several impactful digital twin use cases across drug development, scale-up, and manufacturing, highlighting trends shaping the future of pharma operations. Special guest Magnus Nydén, Executive Director of Innovation at AstraZeneca, will then present a real-world case study, sharing how AstraZeneca is deploying process digital twins, real-time models, and intelligent agents to reduce waste, shorten development timelines, and enable data-driven decision making from API to finished dosage forms.
Speakers:
Magnus Nydén - Director of Innovation at AstraZeneca
Rick Rys- Director of Research at ARC Advisory Group
Register below: